TV News LIES

Kashyap Patel looked forward to his team’s Friday lunches. All the doctors from his oncology practice would gather in the open-air courtyard under the shadow of a tall magnolia tree and catch up. The atmosphere tended to the lighthearted and optimistic. But that week, he was distressed.

With the official start of summer still weeks away, a record-setting heatwave is cooking the south-western US, causing dangerous conditions far earlier than normal.

More than 34 million people were under heat alerts on Thursday afternoon, as warnings were issued from the southern tip of Texas across Arizona and Nevada, and up through the center of California to the northern part of the state.

The brutal conditions are expected to linger through Friday, according to the National Weather Service, as communities across the region brace for days of potentially life-threatening temperatures. Parts of California, the Great Basin and the south-west are forecast to break daily-high temperature records on Thursday and Friday, as Las Vegas, Nevada, and Phoenix, Arizona, hit 110F for the first time this year.

More...

A North Carolina federal judge overruled a spate of new state laws that imposed new requirements on the use of Food and Drug Administration approved abortion pills.

The ruling means that pregnant people can again take the medicine mifepristone at home and can obtain the medication from a pharmacy or by mail. New North Carolina laws had required people to take the medicine only in the physical presence of a licensed physician.

Additionally, an in-person follow up visit is not required, though a requirement remains for people to have an in-person consultation 72 hours prior to taking the medicine. The lawsuit was brought by Dr. Amy Bryant, a UNC Health OB-GYN.

"Politicians in North Carolina cannot interfere with the FDA's authority and impose medically unnecessary restrictions on medication abortion care," Bryant said after the ruling.

More...

A panel of experts advising the Food and Drug Administration on the use of the psychedelic MDMA for post-traumatic stress disorder found on Tuesday that the available evidence fails to show that the drug is effective or that its benefits outweigh its risks.

It represents a major setback for proponents of the drug and its sponsor Lykos Therapeutics, potentially jeopardizing FDA approval of the treatment.

Following public comment and discussion, the panel voted 9-2 that MDMA – in combination with talk therapy – is not effective for treating PTSD. And they voted 10-1 that the benefits of MDMA treatment don’t outweigh its risks.

While the FDA puts stock in the panel’s advice, it does not have to follow their recommendation.

However, that would be surprising given the host of concerns raised during the all-day meeting.

More...

 

A leading federal scientist in Canada has alleged he was barred from investigating a mystery brain illness in the province of New Brunswick and said he fears more than 200 people affected by the condition are experiencing unexplained neurological decline.

The allegations, made in leaked emails to a colleague seen by the Guardian, have emerged two years after the eastern province closed its investigation into a possible “cluster” of cases.

“All I will say is that my scientific opinion is that there is something real going on in [New Brunswick] that absolutely cannot be explained by the bias or personal agenda of an individual neurologist,” wrote Michael Coulthart, a prominent microbiologist. “A few cases might be best explained by the latter, but there are just too many (now over 200).”

More...